SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-20-024885
Filing Date
2020-02-05
Accepted
2020-02-05 08:00:33
Documents
3
Period of Report
2020-02-04
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d875694d8k.htm 8-K 17703
2 EX-99.1 d875694dex991.htm EX-99.1 9118
3 GRAPHIC g875694g0205050433970.jpg GRAPHIC 4937
  Complete submission text file 0001193125-20-024885.txt   35135
Mailing Address 355 ALHAMBRA CIRCLE SUITE 1250 CORAL GABLES FL 33134
Business Address 355 ALHAMBRA CIRCLE SUITE 1250 CORAL GABLES FL 33134 (305) 529-2522
CATALYST PHARMACEUTICALS, INC. (Filer) CIK: 0001369568 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33057 | Film No.: 20576379
SIC: 2834 Pharmaceutical Preparations